Literature DB >> 17192800

Penile rehabilitation after radical prostatectomy: important therapy or wishful thinking?

Joseph E Dall'era, Jesse N Mills, Hari K Koul, Randall B Meacham.   

Abstract

On the basis of data accumulated thus far, it is reasonable to discuss the implementation of a "penile rehabilitation" program with patients undergoing radical prostatectomy. Central to discussions of penile rehabilitation after radical prostatectomy is evidence demonstrating significant fibrotic changes in the corpus cavernosum that occur postoperatively. Several studies have been published evaluating the efficacy of various pro-erectogenic agents. The limited data regarding intracavernous injections and vacuum constriction devices suggest that an increased percentage of treated patients experienced a return of natural erections compared with patients who received no treatment. Longer, prospective, randomized, placebo-controlled studies will be needed to confirm the utility of these treatments. Data from contemporary studies evaluating the chronic use of oral phosphodiesterase type 5 inhibitors suggest a beneficial effect on endothelial cell function among men suffering from erectile dysfunction due to a variety of causes. Limited data suggest that this effect might be seen among post-prostatectomy patients, implying a possible role for these agents in enhancing the return of sexual function in such individuals.

Entities:  

Year:  2006        PMID: 17192800      PMCID: PMC1751036     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  26 in total

1.  Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction.

Authors:  C A Podlasek; C M Gonzalez; D J Zelner; H B Jiang; K E McKenna; K T McVary
Journal:  Int J Impot Res       Date:  2001-12       Impact factor: 2.896

2.  Circulating endothelial progenitor cells in subjects with erectile dysfunction.

Authors:  C Foresta; N Caretta; A Lana; A Cabrelle; G Palù; A Ferlin
Journal:  Int J Impot Res       Date:  2005 May-Jun       Impact factor: 2.896

3.  Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.

Authors:  F Montorsi; G Guazzoni; L F Strambi; L F Da Pozzo; L Nava; L Barbieri; P Rigatti; G Pizzini; A Miani
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

Review 4.  Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors.

Authors:  Frank Sommer; Wolfgang Schulze
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

5.  5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.

Authors:  David F Penson; Dale McLerran; Ziding Feng; Lin Li; Peter C Albertsen; Frank D Gilliland; Ann Hamilton; Richard M Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

6.  Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.

Authors:  M S Litwin; S C Flanders; D J Pasta; M L Stoddard; D P Lubeck; J M Henning
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

7.  Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function.

Authors:  John P Mulhall; Ron Slovick; James Hotaling; Nadid Aviv; Rolando Valenzuela; W Bedford Waters; Robert C Flanigan
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

8.  Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats.

Authors:  R S Rogers; T M Graziottin; C-S Lin; Y W Kan; T F Lue
Journal:  Int J Impot Res       Date:  2003-02       Impact factor: 2.896

9.  Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study.

Authors:  Paolo Gontero; Francesco Fontana; Andrea Bagnasacco; Massimiliano Panella; Ervin Kocjancic; Giulliano Pretti; Bruno Frea
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

10.  PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle.

Authors:  R B Moreland; A Traish; M A McMillin; B Smith; I Goldstein; I Saenz de Tejada
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

View more
  4 in total

1.  Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.

Authors:  Tariq Al Shaiji; Trustin Domes; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

2.  Efficacy of a preprostatectomy multi-modal penile rehabilitation regimen on recovery of postoperative erectile function.

Authors:  Vadim Osadchiy; Sriram V Eleswarapu; Steven A Mills; Matthew E Pollard; Robert E Reiter; Jesse N Mills
Journal:  Int J Impot Res       Date:  2019-09-02       Impact factor: 2.896

3.  A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients.

Authors:  A Natali; L Masieri; M Lanciotti; S Giancane; G Vignolini; M Carini; S Serni
Journal:  Int J Impot Res       Date:  2014-07-24       Impact factor: 2.896

4.  Effectiveness of physiotherapy interventions for improving erectile function and climacturia in men after prostatectomy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Priya Kannan; Stanley J Winser; Lam Choi Ho; Leung C Hei; Lam C Kin; Garbien E Agnieszka; Leung Hy Jeffrey
Journal:  Clin Rehabil       Date:  2019-04-15       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.